We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Rigel Medical - Seaward

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

By HospiMedica International staff writers
Posted on 25 May 2023
Print article
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation of coagulation and healing. Traditional treatments for chronic wounds have primarily involved bandages, negative pressure, and specialized dressings. Skin substitutes have also been employed, although they are expensive and non-autologous. Now, a novel blood-based technology allows healthcare professionals to generate an in-vitro blood clot from a patient's whole blood in real time. This clot can then be applied to act as a protective covering and bolster the wound-healing processes naturally occurring in the patient's body.

RedDress (Tel Aviv, Israel) has pioneered a proprietary blood-based technology to treat chronic wounds that offers nearly zero rejection risk and is significantly more cost-effective. Its product line, ActiGraft, is an autologous point-of-care solution for wound management that produces an in-vitro blood clot from the patient's own whole blood in real-time. Once the clot is applied to the wound, it initiates the wound healing process, acting as a protective covering and enhancing the body's innate healing potential. The ActiGraft product line can be employed for various types of chronic wounds, including diabetic and neuropathic ulcers, venous ulcers, pressure injuries, traumatic wounds, post-surgical wounds, skin tears, and surgical wounds, among others. In 2020, RedDress received FDA clearance and a CE Mark for ActiGraft.

"Healing is in our blood, and we are grateful for the continued support from our investors as we advance our mission of supplying healthcare providers with an effective solution to treat chronic and complex wounds through an innovative system that harnesses the power of patient's own blood," said Alon Kushnir, CEO, and co-founder at RedDress.

Related Links:
RedDress 

Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Digital Ultrasound Scanner
PL-3018I 3D
New
Endoscopic Irrigation Pump
WATERFALL
New
Electric Gynecological Operating Table
YF-6

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Surgical Techniques

view channel
Image: A surgeon visualizing a kidney cancer CT scan to plan his partial nephrectomy (Photo courtesy of AVATAR MEDICAL)

VR Surgical Planning Solution Creates 3D Patient Avatars to Help Surgeons Visualize Medical Images

Virtual reality (VR), now a highly accessible technology, offers a myriad of opportunities, particularly for visualizing and maneuvering through intricate three-dimensional data—a capability that holds... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.